NCT02679235 - Brain Energy and Aging With Triheptanoin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 8, 2018

Study Completion Date

August 8, 2018

Conditions

Frontal Lobe Hypometabolism

Interventions

DRUG

POST Triheptanoin

The target daily dose of triheptanoin will be 1 g/kg/d, or approximately 70 g/d during 28±2 days. It will be divided into four daily doses, one of which will be consumed at each meal and one with an evening snack.

Trial Locations (1)

J1H4C4

Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS), Sherbrooke

All Listed Sponsors

collaborator

Ultragenyx Pharmaceutical Inc

INDUSTRY

collaborator

Fonds de la Recherche en Santé du Québec

OTHER_GOV

lead

Université de Sherbrooke

OTHER